Science Explorer Interactive view Map
City · Canada

Research in Burlington

Science Explorer records 17 research institutions in Burlington, Canada. The highest-ranked on research quality in 2022–2025 are Cytodiagnostics (Canada) and EVERSANA (Canada).

Research institutions
17
2 of them ranked worldwide
Research works
1.3k
▼ 9% vs 2013–17
Top-10% rate, 2022–2025
8.3%
record average 16.5%

A city carries no overall standing here. The composite score is built for institutions and countries, the units its floors and field normalisation were designed around. An empty rank on this page is a statement about the measure, not about the place.

Which research institutions are in Burlington?

#InstitutionWorksAgainst the largest hereWorld rank
1Boehringer Ingelheim (Canada)Company 340 #12,115 all time
2Cytodiagnostics (Canada)Company 288 #20,417
3Nalco (Canada)Company 191 #36,274 all time
4EVERSANA (Canada)Company 161 #20,669
5Semtech (Canada)Company 132 #37,552 all time
6Joseph Brant HospitalHospital / health system 70 not ranked
7Forming Technologies (Canada)Company 57 not ranked
8Outotec (Canada)Company 27 not ranked
9ON Semiconductor (Canada)Company 23 not ranked
10Wescam (Canada)Company 14 not ranked
11EcoSynthetix (Canada)Company 11 not ranked
12Canadian Chlorine Chemistry CouncilGovernment institution 6 not ranked
13Natrix Separations (Canada)Company 5 not ranked
14Johnson Controls (Canada)Company 4 not ranked
15CNH Industrial (Canada)Company 2 not ranked
16Evonik (Canada)Company 2 not ranked
17Ontario Aggregate Resources CorporationInstitution 0 not ranked

By fractional works over the whole record; world rank on research quality in 2022–2025. Bars are scaled to the largest institution in this city, not to anything off the page.

How concentrated the city is

The same institutions as shares of everything the list accounts for. A city that is one university and a city that is twelve read alike as a table and not at all alike here.

Boehringer Ingelheim (Canada): 25.5%Cytodiagnostics (Canada): 21.6%Nalco (Canada): 14.3%EVERSANA (Canada): 12.1%12 others listed: 26.5%26%largest
Boehringer Ingelheim (Canada)340 · 25.5%Cytodiagnostics (Canada)288 · 21.6%Nalco (Canada)191 · 14.3%EVERSANA (Canada)161 · 12.1%12 others listed353 · 26.5%

Shares of the rows listed above, not of the whole node.

What is Burlington strongest at in research?

Relative to its size, research in Burlington is most concentrated in Economics and Econometrics and Economics, Econometrics and Finance (5.4× the world share in Economics and Econometrics).

  1. Economics and EconometricsSubfield · 21.8 works5.4×
  2. Economics, Econometrics and FinanceField · 21.8 works4.0×
← less than its size predicts1×more →

Location quotient against the world baseline. Inside a single field a city is a meaningful unit, which is why this is where a city is measured at all.

Which keywords describe research in Burlington?

By fractional works in 2022–2025, weighted toward what it does more of than the world: Quality of Life, Cost-effectiveness Analysis, Health Utility Measures, Epidemiology, Prognostic Factors, Genetic Mutations, Clinical Trials and Pharmaceutical Industry.

▲ more of its work than of the world’s◆ about the world’s share▼ less than the world’s

Size is fractional works in 2022–2025 in the topics tagged with each word; colour is the word's share of this city's work against its share of the world's. The 40 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 40 words, with their numbers
  1. Quality of Life20▲ 5.4×27 topics
  2. Epidemiology19▲ 1.86×75 topics
  3. Cost-effectiveness Analysis14▲ 66×1 topic
  4. Health Utility Measures14▲ 66×1 topic
  5. Machine Learning8◆ 0.95×18 topics
  6. Inflammation6▲ 1.19×37 topics
  7. Clinical Trials6▲ 3.6×14 topics
  8. Prognostic Factors6▲ 5.2×11 topics
  9. Treatment6▲ 1.84×24 topics
  10. Immunotherapy5▲ 3.0×16 topics
  11. Diagnosis5▲ 2.2×25 topics
  12. Genetic Mutations5▲ 4.9×13 topics
  13. Innovation5▲ 1.82×8 topics
  14. Biomarkers5▲ 2.6×13 topics
  15. Clinical Practice Guidelines4▲ 3.0×10 topics
  16. Heart Failure4▲ 3.9×9 topics
  17. Chemotherapy4▲ 2.3×17 topics
  18. Drug Development Costs4▲ 59×1 topic
  19. Generic Drugs4▲ 59×1 topic
  20. Pharmaceutical Industry4▲ 42×2 topics
  21. Primary Care4▲ 4.1×8 topics
  22. Cardiac Imaging4▲ 12×3 topics
  23. Clinical Guidelines4▲ 5.0×7 topics
  24. Rituximab4▲ 9.3×3 topics
  25. Autoantibodies3▲ 5.2×7 topics
  26. Cardiovascular Risk Assessment3▲ 15×2 topics
  27. Radiation Exposure3▲ 12×2 topics
  28. Coronary Artery Disease3▲ 10×2 topics
  29. Magnetic Resonance Imaging3▲ 4.6×2 topics
  30. Myocardial Infarction3▲ 5.1×3 topics
  31. Computed Tomography Angiography3▲ 17×1 topic
  32. Myocardial Perfusion3▲ 17×1 topic
  33. Clinical Outcomes3▲ 5.1×4 topics
  34. Glycemic Control3▲ 7.1×4 topics
  35. TGF-ß3▲ 7.3×4 topics
  36. Genomic Profiling3▲ 10×2 topics
  37. Biopharmaceuticals2▲ 19×3 topics
  38. Monoclonal Antibodies2▲ 11×3 topics
  39. Immunogenicity2▲ 21×3 topics
  40. Minimal Residual Disease2▲ 13×2 topics

What research is done in Burlington?

Health Systems, Economic…14Health Systems, Economic Evaluations, Quality of Life: 14 fractional worksPharmaceutical Economics and Policy: 4 fractional worksCardiac Imaging and Diagnostics: 3 fractional worksBiosimilars and Bioanalytical Methods: 2 fractional worksChronic Lymphocytic Leukemia Research: 2 fractional worksIntraocular Surgery and Lenses: 2 fractional worksMultiple Myeloma Research and Treatments: 2 fractional worksGut microbiota and health: 2 fractional worksTelemedicine and Telehealth Implementation: 2 fractional worksProstate Cancer Treatment and Research: 2 fractional works
Economics and EconometricsRadiology, Nuclear Medicine and ImagingImmunologyGenetics5 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Health Systems, Economic Evaluations, Quality of Life Economics and Econometrics 14 works
  2. 2 Pharmaceutical Economics and Policy Economics and Econometrics 4 works
  3. 3 Cardiac Imaging and Diagnostics Radiology, Nuclear Medicine and Imaging 3 works
  4. 4 Biosimilars and Bioanalytical Methods Immunology 2 works
  5. 5 Chronic Lymphocytic Leukemia Research Genetics 2 works
  6. 6 Intraocular Surgery and Lenses Ophthalmology 2 works
  7. 7 Multiple Myeloma Research and Treatments Hematology 2 works
  8. 8 Gut microbiota and health Molecular Biology 2 works
  9. 9 Telemedicine and Telehealth Implementation Public Health, Environmental and Occupational Health 2 works
  10. 10 Prostate Cancer Treatment and Research Pulmonary and Respiratory Medicine 2 works

Research output over time

1990200020102020
grewheldshrank

The same series as a ribbon — one cell per year, darker for more.